Race to find COVID-19 treatments accelerates

Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.
No abstract available

Publication types

  • News

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use
  • Betacoronavirus*
  • Biomedical Research / organization & administration*
  • COVID-19
  • COVID-19 Drug Treatment
  • Chloroquine / therapeutic use
  • Clinical Trials as Topic
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / mortality
  • Drug Combinations
  • Humans
  • Hydroxychloroquine / adverse effects
  • Hydroxychloroquine / therapeutic use
  • Lopinavir / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / mortality
  • Ritonavir / therapeutic use
  • SARS-CoV-2
  • World Health Organization

Substances

  • Antiviral Agents
  • Drug Combinations
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • remdesivir
  • Adenosine Monophosphate
  • Hydroxychloroquine
  • Chloroquine
  • Ritonavir
  • Alanine